Zhejiang Jiuzhou Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is OXCARBAZEPINE, with a corresponding US DMF Number 37203.
Remarkably, this DMF maintains an Active status since its submission on June 07, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 15, 2023, and payment made on February 14, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II